These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38363074)

  • 21. [Horizon 2000: what are the perspectives for African trypanosomiasis?].
    De Raadt PP
    Bull Soc Pathol Exot; 1994; 87(5):301-2. PubMed ID: 7496188
    [No Abstract]   [Full Text] [Related]  

  • 22. [Follow - up prognostic study on two imported patients with human African trypanosomiasis].
    Li YY; Chen XL; Liu Q; Wang XY; Chen MX; Liu Q
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2021 Jun; 33(3):293-296. PubMed ID: 34286532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new nonpolar N-hydroxy imidazoline lead compound with improved activity in a murine model of late-stage Trypanosoma brucei brucei infection is not cross-resistant with diamidines.
    Ríos Martínez CH; Miller F; Ganeshamoorthy K; Glacial F; Kaiser M; de Koning HP; Eze AA; Lagartera L; Herraiz T; Dardonville C
    Antimicrob Agents Chemother; 2015 Feb; 59(2):890-904. PubMed ID: 25421467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vitro Anti-trypanosomal and Cytotoxicity Evaluation of 3-methyl-3,4-dihydroquinazolin-2(1H)-one Derivatives.
    Jesumoroti OJ; Beteck RM; Legoabe LJ
    Drug Res (Stuttg); 2021 Jul; 71(6):335-340. PubMed ID: 33535253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VSGs Expressed during Natural T. b. gambiense Infection Exhibit Extensive Sequence Divergence and a Subspecies-Specific Bias towards Type B N-Terminal Domains.
    So J; Sudlow S; Sayeed A; Grudda T; Deborggraeve S; Ngoyi DM; Desamber DK; Wickstead B; Lejon V; Mugnier MR
    mBio; 2022 Dec; 13(6):e0255322. PubMed ID: 36354333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.
    Mesu VKBK; Kalonji WM; Bardonneau C; Mordt OV; Blesson S; Simon F; Delhomme S; Bernhard S; Kuziena W; Lubaki JF; Vuvu SL; Ngima PN; Mbembo HM; Ilunga M; Bonama AK; Heradi JA; Solomo JLL; Mandula G; Badibabi LK; Dama FR; Lukula PK; Tete DN; Lumbala C; Scherrer B; Strub-Wourgaft N; Tarral A
    Lancet; 2018 Jan; 391(10116):144-154. PubMed ID: 29113731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro anti-trypanosomal activity of synthetic nitrofurantoin-triazole hybrids against Trypanosoma species causing human African trypanosomosis.
    Seetsi A; N'da DD; Molefe-Nyembe N; Suganuma K; Ramatla T; Thekisoe O
    Fundam Clin Pharmacol; 2024 Feb; 38(1):72-83. PubMed ID: 37479675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity relationship of dibenzylideneacetone analogs against the neglected disease pathogen, Trypanosoma brucei.
    Francisco KR; Monti L; Yang W; Park H; Liu LJ; Watkins K; Amarasinghe DK; Nalli M; Roberto Polaquini C; Regasini LO; Eduardo Miller Crotti A; Silvestri R; Guidi Magalhães L; Caffrey CR
    Bioorg Med Chem Lett; 2023 Feb; 81():129123. PubMed ID: 36608774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quinolone Amides as Antitrypanosomal Lead Compounds with In Vivo Activity.
    Hiltensperger G; Hecht N; Kaiser M; Rybak JC; Hoerst A; Dannenbauer N; Müller-Buschbaum K; Bruhn H; Esch H; Lehmann L; Meinel L; Holzgrabe U
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4442-52. PubMed ID: 27139467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The treatment of human African trypanosomiasis.
    Pépin J; Milord F
    Adv Parasitol; 1994; 33():1-47. PubMed ID: 8122565
    [No Abstract]   [Full Text] [Related]  

  • 31. The phenomenon of treatment failures in Human African Trypanosomiasis.
    Brun R; Schumacher R; Schmid C; Kunz C; Burri C
    Trop Med Int Health; 2001 Nov; 6(11):906-14. PubMed ID: 11703845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ro 15-0216: a nitroimidazole compound active in vitro against human and animal pathogenic African trypanosomes.
    Borowy NK; Nelson RT; Hirumi H; Brun R; Waithaka HK; Schwartz D; Polak A
    Ann Trop Med Parasitol; 1988 Feb; 82(1):13-9. PubMed ID: 3401068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2-(Nitroaryl)-5-Substituted-1,3,4-Thiadiazole Derivatives with Antiprotozoal Activities: In Vitro and In Vivo Study.
    Mousavi A; Foroumadi P; Emamgholipour Z; Mäser P; Kaiser M; Foroumadi A
    Molecules; 2022 Aug; 27(17):. PubMed ID: 36080325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trypanosoma brucei infection in a HIV positive Ugandan male.
    Dill EA; Renault C; Kirkpatrick BD
    Clin Lab Sci; 2011; 24(2):85-8. PubMed ID: 21657140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiological and proteomic profiles of Trypanosoma brucei rhodesiense parasite isolated from suramin responsive and non-responsive HAT patients in Busoga, Uganda.
    Mutuku CN; Bateta R; Rono MK; Njunge JM; Awuoche EO; Ndung'u K; Mang'era CM; Akoth MO; Adung'a VO; Ondigo BN; Mireji PO
    Int J Parasitol Drugs Drug Resist; 2021 Apr; 15():57-67. PubMed ID: 33588295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diamidines for human African trypanosomiasis.
    Paine MF; Wang MZ; Generaux CN; Boykin DW; Wilson WD; De Koning HP; Olson CA; Pohlig G; Burri C; Brun R; Murilla GA; Thuita JK; Barrett MP; Tidwell RR
    Curr Opin Investig Drugs; 2010 Aug; 11(8):876-83. PubMed ID: 20721830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo evaluation of the antitrypanosomal activity of fractions of Holarrhena africana.
    Nwodo NJ; Brun R; Osadebe PO
    J Ethnopharmacol; 2007 Sep; 113(3):556-9. PubMed ID: 17728085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flavonoid-derived Privileged Scaffolds in anti-Trypanosoma brucei Drug Discovery.
    Boniface PK; Elizabeth FI
    Curr Drug Targets; 2019; 20(12):1295-1314. PubMed ID: 31215385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of megazol on Trypanosoma brucei brucei acute and subacute infections in Swiss mice.
    Bouteille B; Marie-Daragon A; Chauvière G; de Albuquerque C; Enanga B; Dardé ML; Vallat JM; Périé J; Dumas M
    Acta Trop; 1995 Oct; 60(2):73-80. PubMed ID: 8610542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The elimination of human African trypanosomiasis: Achievements in relation to WHO road map targets for 2020.
    Franco JR; Cecchi G; Paone M; Diarra A; Grout L; Kadima Ebeja A; Simarro PP; Zhao W; Argaw D
    PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010047. PubMed ID: 35041668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.